TITLE

Safety of formoterol in children and adolescents: experience from asthma clinical trials

AUTHOR(S)
Price, J. F.; Radner, F.; Lenney, W.; Lindberg, B.
PUB. DATE
December 2010
SOURCE
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Dec2010, Vol. 95 Issue 12, p1047
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background The safety of long-acting �2 agonist (LABA) therapy in asthma remains controversial but no large scale analyses have been published of LABA safety in children. Methods The frequency of asthma-related deaths and hospitalisations following formoterol use in children (4-11 years) and adolescents (12-17 years), compared with non-LABA treatment, was assessed in all AstraZeneca-sponsored, randomised, controlled, parallel-group trials (=3 months) where formoterol was used as maintenance and/or as reliever therapy. Results 11 849 children and adolescents under the age of 18 years from 41 trials were identified, 82% of whom used an inhaled corticosteroid (ICS) as concomitant medication. The number of asthma-related deaths (one 13-year-old boy among 7796 formoterol-treated patients, and none among 4053 non-LABA-treated patients) was too low to allow any between-group comparison. The frequency of patients with asthma-related hospitalisations was not different in formoterol-treated versus non-LABA-treated patients, either in children (1.16% (38/3263) vs 1.11% (24/2165)) or in adolescents (0.51% (23/4533) vs 0.85% (16/1888)). Asthma-related hospitalisations based on daily dose of formoterol were: (A) 4.5 or 9 �g: 1.9% (18/980); (B) 18 �g: 0.5% (14/2870); (C) 36 �g: 0% (0/67); and (D) variable dosing: 0.75% (29/3879). There was no difference between formoterol-treated and non-LABA-treated patients as regards ethnicity. Conclusions Formoterol use in children and adolescents (4-17 years) with asthma in this large study where the majority are prescribed concomitant ICS is not associated with any increased risk of asthma-related hospitalisations. The results are not influenced by dose or ethnicity.
ACCESSION #
60944658

 

Related Articles

  • Budesonide and systemic effects in children with asthma. Pohl, Charles A.; Russell, John J. // Patient Care;Sep2004, Vol. 38 Issue 9, p77 

    Discusses research being done on the long-term systemic effects of inhaled corticosteroids in children with persistent asthma. Reference to a study by L. B. Bacharier et al published in the 2004 issue of "Pediatrics"; Dosage of budesonide received by patients; Findings of the study.

  • Pediatric Asthma Controller Therapy. Anselmo, Mark // Pediatric Drugs;2011, Vol. 13 Issue 1, p11 

    The treatment of children with asthma has historically relied upon expert opinion using data extrapolated from adult studies. Over the past few years, landmark studies have been completed providing healthcare professionals with evidence on which a reasonable approach can be made for children...

  • American Thoracic Society Intl Conference: Baseline characteristics of children with mild persistent asthma predict response to ICS.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article presents information regarding a study according to which relative benefits of using inhaled corticosteroid treatment in children suffering from mild persistent asthma varies with differing demographic and clinical characteristics.

  • Ciclesonide in persistent asthma: the evidence of its therapeutic value. Kenreigh, Charlotte A.; Wagner, Linda Timm; Chrisp, Paul // Core Evidence;2006, Vol. 1 Issue 4, p232 

    Introduction: Asthma, a respiratory disease associated with airway inflammation and hyperresponsiveness, is one of the most prevalent chronic diseases worldwide affecting both children and adults. Inhaled corticosteroids are considered to be the cornerstone of asthma management. Ciclesonide, an...

  • Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone. Chavasse, R. J.; Bastian-Lee, Y.; Richter, H.; Hilliard, T.; Seddon, P. // Archives of Disease in Childhood;Aug2001, Vol. 85 Issue 2, p143 

    Background-The role of inhaled corticosteroids for the treatment of wheeze in infancy remains unclear. Aim-To investigate the effect of inhaled fluticasone on symptoms in a group of wheezy infants who had a high risk of progressing to childhood asthma. Methods-A total of 52 infants, under 1 year...

  • THE DETECTION OF ALLERGIC RHINITIS IN ENGELS TOWNSHIP OF SARATOV REGION SCHOOLCHILD WITH BRONCHIAL ASTHMA: RESULTS OF RETROSPECTIVE ANALYSIS. Tsareva, J. A. // Saratov Journal of Medical Scientific Research / Saratovskii Nau;Jan-Mar2012, Vol. 8 Issue 1, p101 

    The research goal of the study was to assess frequency of allergic rhinitis diagnostics in schoolchildren with bronchial asthma and to evaluate treatment approaches to combined allergic pathology of respiratory tract in clinical practice. Materials: Retrospective analysis of medical records of...

  • Adrenocortical function in asthmatic children: low levels of adrenocortical hormones in children with persistent attacks. Nomura, S.; Fujitaka, M.; Sakura, N.; Ueda, K. // European Journal of Pediatrics;1997, Vol. 156 Issue 4, p323 

    The existence of adrenal dysfunction in asthmatic patients remains controversial. Assessing adrenal function in these patients is difficult because of varying severity and duration of attacks and large fluctuations in the secretion of adrenocortical hormones. Total and free (unbound) levels of...

  • Children do best on fluticasone propionate + salmeterol.  // PharmacoEconomics & Outcomes News;2/6/2010, Issue 596, p4 

    The article summarizes the results of the study "Comparative Clinical and Economic Outcomes in Children with Asthma Initiating Either Fluticasone Propionate Plus Salmeterol or Inhaled Corticosteroids Plus Montelukast," by R. Stanford et al.

  • Seasonal variation in childhood asthma hospitalisations in Finland, 1972–1992. Harju, T.; Keistinen, T.; Tuuponen, T.; Kivelä, S.-L. // European Journal of Pediatrics;1997, Vol. 156 Issue 6, p436 

    All hospital treatment periods caused by asthma in children under 15 years in Finland during 1972–1992 were examined. The data were obtained from the Hospital Discharge Register, covering all hospitalisations in Finland. A total of 59,624 asthma related treatment periods were recorded....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics